Das S, Mazumdar H, Khondakar KR, Kaushik A
The following section contains a review of recent research on ways in which ferroptosis interacts with cancer, especially as regards cancer-related genes, epigenetics, the TME, and so on, and provides a short review of research on ferroptosis regulation and its application to cancer treatment
Who it's for: Patients with chronic bloating, IBS-pattern symptoms, or digestive issues that haven't resolved with standard approaches
Relevant Research Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomised controlled trials Retatrutide for the treatment of obesity, obstructive sleep apnea, and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials Retatrutidea game changer in obesity pharmacotherapy Unleashing the power of retatrutide: a possible triumph over obesity Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomised phase 2a trial Retatrutide in type 2 diabetes mellitus and obesity: an overview
For example, Overexpression of the E3 ubiquitin ligase TRIM7[71] leads to the ubiquitination of NCOA4, inhibiting NCOA4-mediated ferroptosis in GBM[72]